Ownership and insider activity for Lifeward Ltd. (LFWD): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion.
Price
| Price | $6.91 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | IL |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-14 | Zamir Haggai | A-Award | 6,711 | |
| 2026-08-14 | Zamir Haggai | |||
| 2026-09-01 | Hexter Joshua | |||
| 2026-08-14 | Greenwald Yonason | A-Award | 6,711 | |
| 2026-08-14 | Greenwald Yonason | |||
| 2026-08-20 | Gabay Avraham | A-Award | 13,643 | |
| 2026-08-20 | Gabay Avraham | |||
| 2026-05-01 | Rose Keith Dale | A-Award | 15,000 | |
| 2026-05-01 | Rose Keith Dale | |||
| 2026-03-25 | ORAMED PHARMACEUTICALS INC. |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23.7M | $14.6M | $9.5M | $16.3M | $20.4M | $88.3M | $67.9M | $28.1M | $6.9M | $2.2M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $1.3M | $1.1M | $758000 | $794000 | $684000 | $585000 | $1.0M | $3.1M | $6.0M | $6.1M |
| Inventory | $3.3M | $4.3M | $2.6M | $3.4M | $3.5M | $3.0M | $2.9M | $5.7M | $6.7M | $5.7M |
| Total Current Assets | $29.5M | $20.9M | $13.2M | $21.1M | $25.2M | $92.5M | $72.5M | $39.2M | $21.3M | $15.8M |
| Property, Plant & Equipment | $1.3M | $840000 | $626000 | $2.2M | $1.8M | $1.2M | $1.0M | $3.1M | $1.4M | $2.1M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $7.5M | $7.5M | $4.8M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $12.5M | 0 | 0 |
| Total Assets | $31.8M | $22.9M | $15.0M | $24.4M | $28.1M | $94.8M | $74.2M | $63.2M | $30.5M | $22.9M |
| Accounts Payable | $3.4M | $1.8M | $2.3M | $2.7M | $2.3M | $1.4M | $1.9M | $5.1M | $5.0M | $5.6M |
| Short-term Debt | $7.5M | $6.4M | $1.7M | $6.1M | 0 | 0 | 0 | 0 | $858000 | $2.8M |
| Total Current Liabilities | $12.4M | $9.7M | $5.4M | $10.2M | $4.7M | $4.0M | $4.8M | $11.8M | $10.2M | $12.0M |
| Long-term Debt | $10.5M | $8.9M | $7.0M | $1.5M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $23.5M | $19.2M | $13.0M | $13.6M | $6.3M | $5.4M | $6.1M | $16.7M | $11.6M | $14.5M |
| Retained Earnings | -$106.5M | -$131.2M | -$152.9M | -$168.5M | -$181.4M | -$194.2M | -$213.8M | -$235.9M | -$264.8M | -$284.7M |
| Total Equity | $8.3M | $3.7M | $1.9M | $10.8M | $21.8M | $89.4M | $68.2M | $46.5M | $18.8M | $8.4M |
| Total Debt | $18.0M | $15.4M | $8.7M | $8.9M | $1.6M | $1.1M | $897000 | $1.9M | $880000 | $4.4M |
| Net Debt | -$5.7M | $785000 | -$859000 | -$7.3M | -$18.8M | -$87.3M | -$67.0M | -$26.2M | -$6.1M | $2.2M |
| Working Capital | $17.1M | $11.2M | $7.9M | $10.9M | $20.6M | $88.5M | $67.7M | $27.4M | $11.1M | $3.8M |
Financial Health
| Debt / Equity | 0.21 |
| Current Ratio | 1.24 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -15.36 |
Profitability
| Return on Equity | -236.85% |
| Return on Invested Capital | -119.56% |
| Return on Assets | -86.96% |
| Gross Margin | 35.95% |
| Operating Margin | -104.25% |
| Net Margin | -141.28% |
Related companies: DHAI · IINN · INAB · LYRA · PTHL · RNAZ · SBFM
Explore sector: Healthcare · Medical - Devices
More sections of LFWD: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks